Search Within

David H Abramson

Formats
  1. Journal Article (296)
  2. Meeting Abstract (53)
  3. Book Section (15)
  4. Miscellaneous (10)
  5. Review (7)
  6. Correspondence (6)
  7. Editorial (4)
  8. Research Letter (3)
  9. Book Whole (1)
Groups
  1. Pediatrics, Department of (395)
  2. Surgery (395)
  3. Survivorship Research (124)
  4. Neuro-Oncology Service (109)
  5. Department of Medicine (49)
  6. Solid Tumor Oncology Division (47)

More Groups

People
  1. Jasmine Francis (203)
  2. Ira Dunkel (109)
  3. Brian Marr (93)
  4. Scott Brodie (38)
  5. Pierre Gobin (25)
  6. Julia Canestraro (24)

More People

Years
  1. 2025 (13)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (22)
  5. 2021 (25)
  6. 2020 (23)

More Years

Publications
  1. Pediatric Blood and Cancer (33)
  2. Ophthalmology (31)
  3. Investigative Ophthalmology & Visual Science (IOVS) (29)
  4. British Journal of Ophthalmology (23)
  5. Archives of Ophthalmology (19)
  6. PLoS ONE (16)

More Publications

Publishers
  1. Elsevier Science, Inc. (39)
  2. Elsevier Inc. (35)
  3. American Medical Association (33)
  4. Wiley Periodicals, Inc (33)
  5. Association for Research in Vision and Ophthalmology (29)
  6. BMJ Publishing Group Ltd. (28)

More Publishers

Results (395)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mitogen-activated pathway kinase (MAPK) inhibitor-associated retinopathy: Do features differ with upstream versus down-stream inhibition?
    Journal Article

    Francis, J. H.; Foulsham, W.; Canestraro, J.; Harding, J. J.; Diamond, E. L.; Drilon, A.; Abramson, D. H.
    Ocular Oncology and Pathology (2023)

    Fulltext@MSK | Save
  • Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture
    Review

    Abramson, D. H.
    Ophthalmic Genetics (2023)

    Fulltext@MSK | Save
  • Uveal lymphoid hyperplasia: Treatment with combination antibiotics and steroids
    Journal Article

    Francis, J. H.; Winebrake, J. P.; Abramson, D. H.
    British Journal of Ophthalmology (2023)

    Fulltext@MSK | Save
  • Validation of the prognostic usefulness of the gene expression profiling test in patients with uveal melanoma
    Journal Article

    Miguez, S.; Lee, R. Y.; Chan, A. X.; Demkowicz, P. C.; Jones, B. S. C. L.; Long, C. P.; Abramson, D. H.; Bosenberg, M.; Sznol, M.; Kluger, H.; more...
    Ophthalmology (2023)

    Fulltext@MSK | Save
  • Intravitreal topotecan 90 μg for recurrent solid retinoblastoma tumors is effective and not toxic
    Journal Article

    Abramson, D. H.; Francis, J. H.
    Journal of Pediatric Ophthalmology and Strabismus (2023)

    Fulltext@MSK | Save
  • Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-related cancers: A brief review of current status and future prospects
    Review

    Elahi, A. H.; Morales, C. S.; Xu, X. L.; Eliades, A.; Patsalis, P. C.; Abramson, D. H.; Jhanwar, S. C.
    Advances in Biological Regulation (2023)

    Fulltext@MSK | Save
  • Intra-arterial chemotherapy for retinoblastoma
    Editorial

    Carnevale, J. A.; Goldberg, J.; Kocharian, G.; Rivera, M.; Larsen, A. G.; Garton, A.; Ramos, A.; Francis, J. H.; Abramson, D. H.; Gobin, Y. P.
    Journal of Neurointerventional Surgery (2023)

    Fulltext@MSK | Save
  • Ocular findings in patients with histiocytosis
    Meeting Abstract

    Francis, J. H.; Reiner, A. S.; Canestraro, J.; Raajit, R.; Abramson, D. H.; Diamond, E. L.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study
    Journal Article

    Abramson, D. H.; Mandelker, D. L.; Brannon, A. R.; Dunkel, I. J.; Benayed, R.; Berger, M. F.; Arcila, M. E.; Ladanyi, M.; Friedman, D. N.; Jayakumaran, G.; more...
    PLoS ONE (2023)

    Fulltext@MSK | Save
  • Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923–932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933–945)
    Correspondence

    Abramson, D. H.; Shields, C. L.
    Ophthalmology (2023)

    Fulltext@MSK | Save